DGAP-Adhoc: Pulsion Medical Systems SE increases Guidance for FY 2012

| Source: EQS Group AG EQS Group AG 

Pulsion Medical Systems SE  / Key word(s): Change in Forecast

14.01.2013 09:41

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

PULSION increases guidance for FY 2012

 

Regarding full- year 2012, PULSION is providing the following guidance:

 a- Revenues EUR 34.5 - 34.7 Mio.   (2011: EUR 32.9 Mio.)

 b- EBITDA: at least EUR 11.5  Mio.   (2011: EUR 8.7 Mio.)

 c- EBIT: at least EUR 9.5 Mio.    (2011: EUR 6.8 Mio.)

 d- Earnings per share (diluted): 75- 81 Cents.   (2011: 51 Cents)

The 2012 Annual Report will be published on March 21, 2013 prior to the
opening of XETRA.


Contact:

Investor Relations
PULSION Medical Systems SE
Ralph Schäfer
Director Legal Affairs 
Tel.: +49 (0)89 / 459914 211 
Fax: +49 (0)89 / 459914 481 
E-mail: schaefer@pulsion.com


14.01.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Pulsion Medical Systems SE
              Hans-  Riedl-  Straße 21
              85622 Feldkirchen
              Germany
Phone:        +49 (0)89 4599 14-0
Fax:          +49 (0)89 4599 14-18
E-mail:       info@pulsion.com
Internet:     www.pulsion.com
ISIN:         DE0005487904
WKN:          548790
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------